🇺🇸 FDA
Pipeline program

vosoritide

111-209

Phase 2 mab active

Quick answer

vosoritide for Achondroplasia is a Phase 2 program (mab) at BIOMARIN PHARMACEUTICAL INC with 1 ClinicalTrials.gov record(s).

Program details

Company
BIOMARIN PHARMACEUTICAL INC
Indication
Achondroplasia
Phase
Phase 2
Modality
mab
Status
active

Clinical trials